Sunday 17th December, 2017
10.9
31 ℉ | 52 ℉Raleigh
durham-company-sets-terms-of-69m-ipo

Durham company sets terms of $69M IPO

Business Journal - Tuesday 20th June, 2017

Durham-based Dova Pharmaceuticals disclosed in a filing with the SEC on Monday that it will offer 4,062,500 shares of common stock in its initial public offering, at a price of between $15 and $17 per share. The company has applied to list its stock on the Nasdaq exchange under the ticker symbol DOVA.

Dova ' formed in March 2016 ' acquired its drug candidate avatrombopag from Eisai that same month. After completing a pair of successful Phase 3 clinical trials, the company said in the filing...

Read More

More North Carolina State News

Access More
Loading data...
{{item.TITLE}}

{{item.SOURCE}}

North Carolina State News.Net

{{item.TITLE}}

{{item.SOURCE}}

North Carolina State News.Net

Sign up for North Carolina State News

a daily newsletter full of things to discuss over drinks.and the great thing is that it's on the house!